Yamamoto, Gaku
Asahina, Hajime
Honjo, Osamu
Sumi, Toshiyuki
Nakamura, Atsushi
Ito, Kenichiro
Kikuchi, Hajime
Hommura, Fumihiro
Honda, Ryoichi
Yokoo, Keiki
Fujita, Yuka
Oizumi, Satoshi
Morita, Ryo
Ikezawa, Yasuyuki
Tanaka, Hisashi
Kimura, Nozomu
Sasaki, Takaaki
Sukoh, Noriaki
Takashina, Taichi
Harada, Toshiyuki
Dosaka-Akita, Hirotoshi
Isobe, Hiroshi
,
Yamamoto, Gaku
Asahina, Hajime
Honjo, Osamu
Sumi, Toshiyuki
Nakamura, Atsushi
Ito, Kenichiro
Isobe, Hiroshi
Kikuchi, Hajime
Hommura, Fumihiro
Honda, Ryoichi
Yokoo, Keiki
Fujita, Yuka
Oizumi, Satoshi
Morita, Ryo
Ikezawa, Yasuyuki
Tanaka, Hisashi
Kimura, Nozomu
Sasaki, Takaaki
Sukoh, Noriaki
Takashina, Taichi
Harada, Toshiyuki
Akita, Hirotoshi
Article History
Received: 3 July 2021
Accepted: 18 November 2021
First Online: 30 November 2021
Competing interests
: H.A. received lecture fees from Chugai Pharmaceutical. S.O. received a research grant from AstraZeneca, Amgen, AbbVie, Kissei Pharmaceutical, Sanofi, Taiho Pharmaceutical, Takeda Pharmaceutical, Chugai Pharmaceutical, Pfizer, Bristol-Myers squib, and Merck BioPharma, in addition to lecture fees from AstraZeneca and Eli Lilly Japan. T.S. received a research grant from Pfizer and Boehringer Ingelheim Japan. The other authors declare no competing interests.